ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 290 filers reported holding ARGENX SE in Q2 2023. The put-call ratio across all filers is 1.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,333,841 | +76.7% | 39,326 | +40.1% | 0.06% | +57.9% |
| Q2 2023 | $10,939,331 | -37.4% | 28,069 | -40.2% | 0.04% | -38.7% |
| Q1 2023 | $17,486,670 | +34037.0% | 46,934 | -65.3% | 0.06% | -66.5% |
| Q4 2022 | $51,225 | -98.8% | 135,219 | +1043.3% | 0.18% | +1056.2% |
| Q3 2022 | $4,176,000 | +282.1% | 11,827 | +310.1% | 0.02% | +300.0% |
| Q2 2022 | $1,093,000 | -17.0% | 2,884 | -31.0% | 0.00% | 0.0% |
| Q1 2022 | $1,317,000 | +16.3% | 4,178 | +29.3% | 0.00% | +33.3% |
| Q4 2021 | $1,132,000 | +208.4% | 3,232 | +165.8% | 0.00% | +200.0% |
| Q3 2021 | $367,000 | -87.9% | 1,216 | -89.0% | 0.00% | -91.7% |
| Q1 2021 | $3,037,000 | +42.6% | 11,029 | +36.0% | 0.01% | 0.0% |
| Q3 2020 | $2,129,000 | – | 8,111 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |